unfortunately the only ppl buying this are punters....it was a small, non-blind trial(taken by participants in the "comfort of their homes")....not clinical for the FDA....and there is no stock available, so we saw demand go berserk.
The results are interesting...but there is a long way to go.
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica, page-135
Add ZLD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.055(12.4%) |
Mkt cap ! $4.425M | |||
| Open | High | Low | Value | Volume |
| 41.0¢ | 42.0¢ | 38.0¢ | $6.402K | 15.75K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3880 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 361 | 1 |
View Market Depth
| Last trade - 15.51pm 09/07/2024 (20 minute delay) ? |
| ZLD (ASX) Chart |